Marilyn L. Moy MD

Adjunct Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine

72 E. Concord Street
Marilyn Moy
Sections

Pulmonary, Allergy, Sleep & Critical Care Medicine

Biography

Marilyn L. Moy, M.D., M.Sc., Associate Professor of Medicine, Harvard Medical School, is a Staff Pulmonary Physician at VA Boston Healthcare System. She is Medical Director of the Pulmonary Rehabilitation Program, accredited by the American Association of Cardiovascular and Pulmonary Rehabilitation. Dr. Moy studies the role of physical activity (PA) in the risk stratification of COPD, technology-based interventions to promote PA, and the biological mechanisms underlying the beneficial effects of PA on COPD outcomes. Her work has contributed to the field of telehealth medicine.

Dr. Moy is internationally recognized as an expert in Pulmonary Rehabilitation. She was the 2016-2017 Chair of the Program Committee of the Rehabilitation Assembly of the American Thoracic Society. She has been an invited speaker at the European Respiratory Congress in Munich, Germany and Amsterdam, Holland. She serves on the Research Advocacy Committee of the ATS.

As the Principal Investigator on VA and NIH funded grants, Dr. Moy published one of the first papers demonstrating that low PA is associated with increased risk for acute exacerbations in COPD. Dr. Moy has developed a novel internet-mediated, pedometer based intervention to promote PA in COPD. Her work was recognized with the 2017 Massachusetts Pulmonary Section award for best clinical research abstract. Dr. Moy also examines biological mechanisms including the relationship between PA and telomere length, and the epigenetic changes associated with improvements in PA. Dr. Moy is VA Boston's 2017 nominee for the Presidential Early Career Award for Scientists and Engineers.

Dr. Moy is a Co-Investigator for a pragmatic trial examining a PA coaching intervention (PCORI), and a trial on the efficacy of Tai Chi to maintain benefits after conventional pulmonary rehabilitation in COPD (NIH-NCCIH). Dr. Moy has been the site-PI for NHLBI clinical trials.

Education

Medicine, MD, Harvard Medical School, 1992

Epidemiology, MSc, Harvard School of Public Health, 2000

Biology, AB, Radcliffe College, 1988

Publications

Published on 8/31/2021

Robinson SA, Cooper JA, Goldstein RL, Polak M, Cruz Rivera PN, Gagnon DR, Samuelson A, Moore S, Kadri R, Richardson CR, Moy ML. A randomised trial of a web-based physical activity self-management intervention in COPD. ERJ Open Res. 2021 Jul; 7(3). PMID: 34476247.

Published on 8/25/2021

Demeyer H, Mohan D, Burtin C, Vaes A, Heasley M, Bowler R, Casaburi R, Cooper CB, Corriol-Rohou S, Frei A, Hamilton A, Hopkinson NS, Karlsson N, Man WD, Moy ML, Pitta F, Polkey MI, Puhan M, Rennard SI, Rochester CL, Rossiter HB, Sciurba F, Singh S, Tal-Singer R, Vogiatzis I, Watz H, Lummel RV, Wyatt J, Merrill DD, Spruit MA, Garcia-Aymerich J, Troosters T. Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity. Chronic Obstr Pulm Dis. 2021 08 25. PMID: 34433239.

Published on 8/14/2021

Wan ES, Goldstein RL, Garshick E, DeMeo DL, Moy ML. Molecular markers of aging, exercise capacity, & physical activity in COPD. Respir Med. 2021 Aug 14; 187:106576. PMID: 34416615.

Published on 7/15/2021

Moy ML, Daniel RA, Cruz Rivera PN, Mongiardo MA, Goldstein RL, Higgins DM, Salat DH. Co-occurrence of pain and dyspnea in Veterans with COPD: Relationship to functional status and a pilot study of neural correlates using structural and functional magnetic resonance imaging. PLoS One. 2021; 16(7):e0254653. PMID: 34265003.

Published on 7/15/2021

Raphaely RA, Mongiardo MA, Goldstein RL, Robinson SA, Wan ES, Moy ML. Pain in Veterans with COPD: relationship with physical activity and exercise capacity. BMC Pulm Med. 2021 Jul 15; 21(1):238. PMID: 34266401.

Published on 7/12/2021

Moy ML, Wayne PM, Litrownik D, Beach D, Klings ES, Davis RB, Pinheiro A, Yeh GY. Long-term Exercise After Pulmonary Rehabilitation (LEAP): a pilot randomised controlled trial of Tai Chi in COPD. ERJ Open Res. 2021 Jul; 7(3). PMID: 34262967.

Published on 7/1/2021

Burtin C, Mohan D, Troosters T, Watz H, Hopkinson NS, Garcia-Aymerich J, Moy ML, Vogiatzis I, Rossiter HB, Singh S, Merrill DD, Hamilton A, Rennard SI, Fageras M, Petruzzelli S, Tal-Singer R, Tomaszewski E, Corriol-Rohou S, Rochester CL, Sciurba FC, Casaburi R, Man WD, Van Lummel RC, Cooper CB, Demeyer H, Spruit MA, Vaes A. Objectively Measured Physical Activity as a COPD Clinical Trial Outcome. Chest. 2021 Jul 01. PMID: 34217679.

Published on 6/9/2021

Kraemer KM, Litrownik D, Moy ML, Wayne PM, Beach D, Klings ES, Reyes Nieva H, Pinheiro A, Davis RB, Yeh GY. Exploring Tai Chi Exercise and Mind-Body Breathing in Patients with COPD in a Randomized Controlled Feasibility Trial. COPD. 2021 06; 18(3):288-298. PMID: 34106027.

Published on 5/15/2021

Gilliam EA, Kilgore KL, Liu Y, Bernier L, Criscitiello S, Litrownik D, Wayne PM, Moy ML, Yeh GY. Managing the experience of breathlessness with Tai Chi: A qualitative analysis from a randomized controlled trial in COPD. Respir Med. 2021 08; 184:106463. PMID: 34023739.

Published on 5/10/2021

Dragnich AG, Yee N, Gylys-Colwell I, Locke ER, Nguyen HQ, Moy ML, Magzamen S, Fan VS. Sociodemographic Characteristics and Physical Activity in Patients with COPD: A 3-Month Cohort Study. COPD. 2021 06; 18(3):265-271. PMID: 33970723.

View full list of 57 publications.